Search results
Results from the WOW.Com Content Network
By mid-2014, Accelerator, a biotech investment firm, had raised more than US$30 million from investors, including Eli Lilly and Company, Pfizer, and Johnson & Johnson, for initial funding to create biotechnology startups at the Alexandria Center for Life Science, which encompasses more than 700,000 square feet (65,000 m 2) on East 29th Street ...
Pfizer has so far signed up less than a quarter of the countries targeted under a plan to make its medicines available to the world’s poorest nations at not-for-profit prices, just over two ...
Today, the organization engages in an increasing amount of global data collection, too. The Center continues to be publisher and distributor of its own directories, research reports, and nonprofit management and fundraising guides, and makes its databases available via Foundation Directory Online, Foundation Maps, and other online resources.
For premium support please call: 800-290-4726 more ways to reach us
In June 2022, Roivant and Pfizer unveiled Priovant Therapeutics. [22] Priovant was established in September 2021 through a transaction between Roivant and Pfizer, [23] in which Pfizer licensed oral and topical brepocitinib's global development rights and US and Japan commercial rights to Priovant. Pfizer holds a 25% equity ownership interest in ...
In 2022, Pfizer expanded its partnership with CytoReason with a $20 million investment that could reach $110 million by 2027. "The rapid expansion of new technologies, like artificial
Show-Me Institute: St. Louis: Missouri: Free market 2014 Social Science Research Council: Brooklyn: New York: Independent 1923 SRI International: Menlo Park: California: Nonpartisan 1946 Sunwater Institute North Bethesda: Maryland: Nonpartisan 2017 Tax Foundation: New York: New York: Center 1937 Texas Public Policy Foundation: Austin: Texas ...
A judge dismissed Pfizer Inc's challenge to a U.S. anti-kickback law that the drugmaker said prevents it from helping Medicare patients afford two drugs that treat a sometimes fatal heart ...